A new machine learning model gives a personalized prognosis for patients

The number of treatments for multiple myeloma has dramatically expanded in the past two decades. That’s great news but with so many options, clinicians need better ways to determine which treatment is going to work best for each patient. Tools like the computational model dubbed the Individual Risk Model for Myeloma, or IRMMa, are the future for optimising treatment and management.